|
|
Volumn 29, Issue 2, 2013, Pages 90-91
|
|
Eyes on new product development: Ophthalmic drug delivery
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFLIBERCEPT;
DEXAMETHASONE;
DIPIVEFRINE;
EBI 005;
EGP 437;
FLUOCINOLONE ACETONIDE;
GANCICLOVIR;
GEVOKIZUMAB;
ORPHAN DRUG;
PILOCARPINE;
PROTEIN KINASE SYK INHIBITOR;
R 348;
RANIBIZUMAB;
RV 001;
UNCLASSIFIED DRUG;
UNOPROSTONE ISOPROPYL ESTER;
DIABETIC MACULAR EDEMA;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG SAFETY;
DRY EYE;
ENDOCRINE OPHTHALMOPATHY;
GLAUCOMA;
HUMAN;
IONTOPHORESIS;
IRIDOCYCLITIS;
NANOTECHNOLOGY;
NOTE;
OPEN ANGLE GLAUCOMA;
RETINA DEGENERATION;
RETINA MACULA EDEMA;
RETINOBLASTOMA;
ADMINISTRATION, OPHTHALMIC;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
DRUG DELIVERY SYSTEMS;
DRUG INDUSTRY;
EYE DISEASES;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
|
|
EID: 84875012462
PISSN: 10807683
EISSN: 15577732
Source Type: Journal
DOI: 10.1089/jop.2013.1503 Document Type: Note |
|
Times cited : (2)
|
|
References (1)
|
